Enanta Pharmaceuticals
ENTA
#7600
Rank
ยฃ0.29 B
Marketcap
ยฃ10.11
Share price
2.37%
Change (1 day)
155.78%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ70.95 Million, an increase over its 2023 earnings that were of -ยฃ93.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-18.32%
2024 -ยฃ70.95 Million-23.87%
2023 -ยฃ93.19 Million4.39%
2022 -ยฃ89.27 Million-4.4%
2021 -ยฃ93.38 Million91.12%
2020 -ยฃ48.87 Million-407.13%
2019 ยฃ15.9 M-78.63%
2018 ยฃ74.45 M117.97%
2017 ยฃ34.15 M-574.65%
2016 -ยฃ7.2 Million-110.83%
2015 ยฃ66.46 M-4.5%
2014 ยฃ69.59 M-638.53%
2013 -ยฃ12.93 Million-137.98%
2012 ยฃ34.02 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.69 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.95 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ1.21 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.26 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.88 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.87 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA